SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000921895-19-000758
Filing Date
2019-03-15
Accepted
2019-03-15 16:40:50
Documents
2

Document Format Files

Seq Description Document Type Size
1 THE SCHEDULE 13D sc13d07422010_03152019.htm SC 13D 223317
2 JOINT FILING AGREEMENT ex991to13d07422010_03152019.htm EX-99.1 10818
  Complete submission text file 0000921895-19-000758.txt   235689
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 6282 Investment Advice

Mailing Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 800 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-995-8200
OncoMed Pharmaceuticals Inc (Subject) CIK: 0001302573 (see all company filings)

IRS No.: 383572512 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-87757 | Film No.: 19685551
SIC: 2834 Pharmaceutical Preparations